content

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics ....

Sharp Announces $650K Investment to Enhances IRT Solution

Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and...

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with CD30+ Stage IV Hodgkin Lymphoma

Takeda Pharmaceutical Co. announced that the EC extended the current marketing authorization of ADCETRIS to include treatment of adult patients with previously untreated CD30+...

Ompi and SiO2 Medical Products sign collaboration agreement

Ompi, the Italian glass primary packaging specialist for the pharmaceutical industry, has signed a collaboration agreement with SiO2 Medical Products (SMP). ...

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple...

CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit

Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experience. ...

Lonza Launches New Reliable, Robust and Customizable Pooled Donor Suspension Hepatocytes

Lonza announces the launch of DonorPlex Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read